Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2026-03-15 @ 9:08 PM
Study NCT ID:
NCT02725112
Status:
COMPLETED
Last Update Posted:
2021-01-20
First Post:
2016-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A0081309
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None